Voyager Therapeutics Highlights Programs in Parkinson’s Disease and ALS; Announces Expansion of CNS Pipeline at R&D Day

M.D., professor and chair of neurology at the University of Massachusetts Medical Center and Medical School and director of the Day Neuromuscular Research Laboratory ... a monogenic form of amyotrophic lateral sclerosis (ALS), Friedreich's ataxia ...